Insights

Global Expansion PolyNovo is actively expanding through exclusive sales and distribution rights in the UK, Northern Europe, and Europe, signaling opportunities to partner on regional market access, registrations, and expansion of product lines including SUPRATHEL in new territories.

Strategic Partnerships Collaboration with Spectral AI to bring DeepView System for burn indications in Australia opens a pathway for diagnostic-support offerings alongside wound care products, suggesting joint sale or bundled solutions for burn care facilities.

R&D Funding A Victorian Government grant boosts R&D capabilities for polymer-based tissue engineering, indicating potential for advanced wound care innovations that can be co-developed or funded in collaboration with healthcare providers seeking cutting-edge solutions.

Leadership & Governance New appointments in legal and executive leadership (general counsel, company secretary, and prior CEO changes) emphasize governance maturity and potential for structured sales operations, contracts, and channel partnerships.

Growth Footprint With over 106,000 treated patients across 46 countries and a revenue profile in the mid-market range, PolyNovo offers an attractive platform for value-based selling to large hospital networks and regional health systems seeking standardized, differentiated wound care solutions.

Similar companies to PolyNovo Limited

PolyNovo Limited Tech Stack

PolyNovo Limited uses 8 technology products and services including The Trade Desk, Canva, WordPress, and more. Explore PolyNovo Limited's tech stack below.

Media & News

PolyNovo Limited's Email Address Formats

PolyNovo Limited uses at least 2 email formats:
PolyNovo Limited Email FormatsExamplePercentage
First.Last@polynovo.comJohn.Doe@polynovo.com
76%
First.L@polynovo.comJohn.D@polynovo.com
24%

Frequently Asked Questions

What is PolyNovo Limited's phone number?

Minus sign iconPlus sign icon
You can contact PolyNovo Limited's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is PolyNovo Limited's official website and social media links?

Minus sign iconPlus sign icon
PolyNovo Limited's official website is polynovo.com and has social profiles on LinkedIn.

How much revenue does PolyNovo Limited generate?

Minus sign iconPlus sign icon
As of August 2026, PolyNovo Limited's annual revenue is estimated to be $25M - $50M.

What is PolyNovo Limited's SIC code and NAICS code?

Minus sign iconPlus sign icon
PolyNovo Limited's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does PolyNovo Limited have currently?

Minus sign iconPlus sign icon
As of August 2026, PolyNovo Limited has approximately 311 employees across 4 continents, including Oceania, North America and Asia. Key team members include Chief Executive Officer: B. P., Chief Executive Officer: I. G. and Cfo & Company Secretary: J. G. Explore PolyNovo Limited's employee directory with LeadIQ.

What industry does PolyNovo Limited belong to?

Minus sign iconPlus sign icon
PolyNovo Limited operates in the Medical Equipment Manufacturing industry.

What technology does PolyNovo Limited use?

Minus sign iconPlus sign icon
PolyNovo Limited's tech stack includes The Trade Desk, Canva, WordPress, Salesforce, ADP, Smartsheet, Miro and Piwik PRO Core.

What is PolyNovo Limited's email format?

Minus sign iconPlus sign icon
PolyNovo Limited's email format typically follows the pattern of First.Last@polynovo.com. Find more PolyNovo Limited email formats with LeadIQ.
PolyNovo Limited logo

PolyNovo Limited

Medical Equipment ManufacturingVictoria, Australia201-500 Employees

PolyNovo Limited is a mid-sized medical device company based in Port Melbourne, Victoria, Australia, focused on wound-care innovations. Its products are designed to support the treatment of acute, complex wounds and to achieve improved healing outcomes across a variety of wound types. The company has treated more than 106,000 patients across 46 countries, reflecting a broad clinical footprint. It operates in the medical equipment manufacturing sector and seeks growth by expanding its product portfolio, new clinical indications, and geographic reach.

The firm employs hundreds of staff, indicating a mid-sized organization. In July 2024, PolyNovo announced a collaboration with Spectral AI to introduce the DeepView System for burn indications to the Australian market.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $25M - $50M

    PolyNovo Limited's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.